NVAX•benzinga•
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
Summary
Novavax ends UK COVID-19 vaccine contract, agreeing to repay $123.8M in quarterly installments by 2027 as part of settlement.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga